These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21865887)

  • 21. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment.
    Counts SE; Nadeem M; Lad SP; Wuu J; Mufson EJ
    J Neuropathol Exp Neurol; 2006 Jun; 65(6):592-601. PubMed ID: 16783169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.
    Lleó A; Irwin DJ; Illán-Gala I; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
    JAMA Neurol; 2018 Jun; 75(6):738-745. PubMed ID: 29554190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.
    Uryu K; Nakashima-Yasuda H; Forman MS; Kwong LK; Clark CM; Grossman M; Miller BL; Kretzschmar HA; Lee VM; Trojanowski JQ; Neumann M
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):555-64. PubMed ID: 18520774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI.
    Aluise CD; Robinson RA; Cai J; Pierce WM; Markesbery WR; Butterfield DA
    J Alzheimers Dis; 2011; 23(2):257-69. PubMed ID: 20930294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
    Armstrong RA; Carter D; Cairns NJ
    Neuropathol Appl Neurobiol; 2012 Feb; 38(1):25-38. PubMed ID: 21696412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
    DeKosky ST; Ikonomovic MD; Styren SD; Beckett L; Wisniewski S; Bennett DA; Cochran EJ; Kordower JH; Mufson EJ
    Ann Neurol; 2002 Feb; 51(2):145-55. PubMed ID: 11835370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aβ oligomers accumulation.
    Caccamo A; Magrí A; Oddo S
    Mol Neurodegener; 2010 Nov; 5():51. PubMed ID: 21070634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis.
    Forman MS; Mufson EJ; Leurgans S; Pratico D; Joyce S; Leight S; Lee VM; Trojanowski JQ
    Neurology; 2007 Mar; 68(10):757-63. PubMed ID: 17339583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
    Takeda T
    Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.
    Ikonomovic MD; Wecker L; Abrahamson EE; Wuu J; Counts SE; Ginsberg SD; Mufson EJ; Dekosky ST
    Arch Neurol; 2009 May; 66(5):646-51. PubMed ID: 19433665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome.
    Lippa CF; Rosso AL; Stutzbach LD; Neumann M; Lee VM; Trojanowski JQ
    Arch Neurol; 2009 Dec; 66(12):1483-8. PubMed ID: 20008652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease.
    Julien C; Tremblay C; Emond V; Lebbadi M; Salem N; Bennett DA; Calon F
    J Neuropathol Exp Neurol; 2009 Jan; 68(1):48-58. PubMed ID: 19104446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-amyloid triggers ALS-associated TDP-43 pathology in AD models.
    Herman AM; Khandelwal PJ; Stanczyk BB; Rebeck GW; Moussa CE
    Brain Res; 2011 Apr; 1386():191-9. PubMed ID: 21376022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice.
    Murphy MP; Beckett TL; Ding Q; Patel E; Markesbery WR; St Clair DK; LeVine H; Keller JN
    Neurobiol Dis; 2007 Sep; 27(3):301-11. PubMed ID: 17651976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.
    Koivunen J; Scheinin N; Virta JR; Aalto S; Vahlberg T; Någren K; Helin S; Parkkola R; Viitanen M; Rinne JO
    Neurology; 2011 Mar; 76(12):1085-90. PubMed ID: 21325653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
    Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.
    Gao J; Wang L; Gao C; Arakawa H; Perry G; Wang X
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165580. PubMed ID: 31678156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
    Villemagne VL; Rowe CC
    J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.